On March 30, 2017, Tai Heng received an official closeout letter from US FDA. Based upon Tai Heng’s response and recent inspection outcome, US FDA has evaluated and found all issues have been corrected and satisfactory. It is also an encouragement to Tai Heng’s new management team during last 10 months' around-the-clock effort to improve and solidify the Quality system in-house.
返回
上海泰亨实业集团有限公司
021-34622476
cindys@taihengco.com
微信公众号